[fcb5af]: / literature / by_gene / KLF2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 29657712 10.12688/f1000research.13826.1 2022 Recent advances in understanding the biology of marginal zone lymphoma. KLF2
2 34494161 10.1007/s00428-021-03186-3 2022 Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. KLF2
3 34582557 10.1182/blood.2021012091 2022 PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma. KLF2
4 34653238 10.1182/blood.2021012386 2022 Genetic and phenotypic attributes of splenic marginal zone lymphoma. KLF2
5 35030632 10.1182/bloodadvances.2021006410 2022 Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. KLF2
6 35205796 10.3390/cancers14041050 2022 Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. KLF2
7 35339566 10.1016/j.humpath.2022.03.008 2022 Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation. KLF2
8 35454811 10.3390/cancers14081904 2022 Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. KLF2
9 35687490 10.1182/bloodadvances.2021006654 2022 Genomic characterization of lymphomas in patients with inborn errors of immunity. KLF2
10 32723198 10.1080/10428194.2020.1797006 2021 RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events. KLF2
11 32732678 10.1097/PPO.0000000000000463 2021 Marginal Zone Lymphomas. KLF2
12 32947237 10.1016/j.tranon.2020.100855 2021 Identification of clinical molecular targets for childhood Burkitt lymphoma. KLF2
13 33968070 10.3389/fimmu.2021.666935 2021 Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells. KLF2
14 30002791 10.1016/j.csbj.2018.06.001 2020 Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges. KLF2
15 31144355 10.1002/jcb.28861 2020 MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer's disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. KLF2
16 31320741 10.1038/s41598-019-46906-1 2020 Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. KLF2
17 31713921 10.1002/jcb.29517 2020 Downregulated microRNA-92a-3p inhibits apoptosis and promotes proliferation of pancreatic acinar cells in acute pancreatitis by enhancing KLF2 expression. KLF2
18 32075248 10.3390/microorganisms8020258 2020 Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer. KLF2
19 29989027 10.18632/oncotarget.25601 2019 New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. KLF2
20 30623224 10.1007/s00347-018-0840-8 2019 [New molecular pathological strategies for malignant iris tumors]. KLF2
21 27121112 10.3109/10428194.2016.1173212 2018 Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. KLF2
22 28522570 10.3324/haematol.2016.161711 2018 Clinical and diagnostic relevance of <i>NOTCH2</i>-and <i>KLF2</i>-mutations in splenic marginal zone lymphoma. KLF2
23 28751561 10.3324/haematol.2016.160192 2018 Exome sequencing identifies recurrent <i>BCOR</i> alterations and the absence of <i>KLF2</i>, <i>TNFAIP3</i> and <i>MYD88</i> mutations in splenic diffuse red pulp small B-cell lymphoma. KLF2
24 26989207 10.1182/blood-2015-11-624312 2017 Splenic marginal zone lymphoma: from genetics to management. KLF2
25 27197189 10.1158/0008-5472.CAN-15-2698 2017 Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma. KLF2
26 27335277 10.1182/blood-2016-02-696757 2017 The genetics of nodal marginal zone lymphoma. KLF2
27 27503810 10.1016/j.semcancer.2016.08.002 2017 NF-κB deregulation in splenic marginal zone lymphoma. KLF2
28 28188237 10.1042/CS20160930 2017 First identification of <i>Krüppel-like factor 2</i> mutation in heritable pulmonary arterial hypertension. KLF2
29 28288718 10.1016/j.beha.2016.09.005 2017 Splenic marginal zone lymphoma. KLF2
30 28297625 10.1200/JCO.2016.71.1556 2017 Genomics of Hairy Cell Leukemia. KLF2
31 28892161 10.1002/path.4982 2017 A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. KLF2
32 25728499 10.1111/apha.12476 2016 Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. KLF2
33 25779943 10.1158/1078-0432.CCR-14-2759 2016 Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. KLF2
34 25283840 10.1038/leu.2014.294 2015 The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. KLF2
35 25428260 10.1038/leu.2014.330 2015 KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. KLF2
36 25612624 10.1182/blood-2014-08-596247 2015 DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. KLF2